If you are not able to use OpenClaw on Windows 11, use the built-in diagnostic tool, switch to WSL2 instead of PowerShell, ...

Landmark, third-party research strengthens evidence of long-term impact beyond a single Girls on the Run season. CHARLOTTE, NC, UNITED STATES, March 25, 2026 ...

Mayor Zohran Mamdani’s drive to expand “free” (city-run, taxpayer-funded) preschool programs is already squeezing private-sector providers, suggesting this “transformation” is more about a government ...

State lawmakers might reduce funding for Running Start, a program that lets high school juniors and seniors take courses and earn credits at community and technical colleges. Running Start students ...

CHARLESTON — A nonprofit run by City Councilman Aaron Polkey, who was sworn in last month, is set to receive nearly $240,000 from the city for a homeless program. Polkey, president and CEO of Palmetto ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

Social Security, which provides benefits to about 70 million Americans, could run out of money sooner than expected, according to a new report from the Congressional Budget Office. The Old-Age and ...

DAYTON, Ohio (WDTN) – Wright State University has been given a full membership for the U.S. Space Command’s Academic Engagement Enterprise. This is currently only available to a select group of ...

Current school board member Rae Gallagher said she hopes to continue preserving protections and programs for students in her reelection run for the Frederick County Board of Education. She said she ...

Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.